End-of-day quote
Shenzhen S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
11.8
CNY
|
+1.29%
|
|
+11.85%
|
-31.28%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
3,242
|
3,293
|
2,658
|
2,558
|
2,278
|
2,164
|
Enterprise Value (EV)
1 |
2,806
|
2,873
|
2,269
|
2,323
|
2,097
|
2,038
|
P/E ratio
|
34.6
x
|
32.2
x
|
27.4
x
|
47.3
x
|
-29.8
x
|
261
x
|
Yield
|
1%
|
0.98%
|
1.19%
|
-
|
-
|
-
|
Capitalization / Revenue
|
10.9
x
|
8.67
x
|
6
x
|
5.55
x
|
7.03
x
|
5.13
x
|
EV / Revenue
|
9.41
x
|
7.57
x
|
5.12
x
|
5.04
x
|
6.48
x
|
4.83
x
|
EV / EBITDA
|
31.5
x
|
29.3
x
|
21.4
x
|
38.4
x
|
-31
x
|
54.9
x
|
EV / FCF
|
11,226
x
|
-139
x
|
93.7
x
|
-39.4
x
|
-101
x
|
-31.6
x
|
FCF Yield
|
0.01%
|
-0.72%
|
1.07%
|
-2.54%
|
-0.99%
|
-3.16%
|
Price to Book
|
5.36
x
|
4.88
x
|
3.59
x
|
3.28
x
|
3.32
x
|
3.1
x
|
Nbr of stocks (in thousands)
|
126,049
|
126,049
|
126,049
|
126,048
|
126,048
|
126,048
|
Reference price
2 |
25.72
|
26.13
|
21.08
|
20.29
|
18.07
|
17.17
|
Announcement Date
|
3/15/19
|
4/23/20
|
4/23/21
|
2/25/22
|
4/23/23
|
4/25/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
298
|
379.6
|
443.1
|
461.2
|
323.8
|
422.2
|
EBITDA
1 |
88.96
|
98.18
|
106.1
|
60.55
|
-67.56
|
37.09
|
EBIT
1 |
80.07
|
88.81
|
96.49
|
48.12
|
-80.72
|
24.42
|
Operating Margin
|
26.87%
|
23.39%
|
21.78%
|
10.43%
|
-24.93%
|
5.78%
|
Earnings before Tax (EBT)
1 |
83.74
|
117.8
|
111.9
|
55.3
|
-90.71
|
13.81
|
Net income
1 |
70.09
|
102.3
|
96.96
|
54.06
|
-76.38
|
8.277
|
Net margin
|
23.52%
|
26.96%
|
21.88%
|
11.72%
|
-23.59%
|
1.96%
|
EPS
2 |
0.7436
|
0.8119
|
0.7693
|
0.4289
|
-0.6059
|
0.0657
|
Free Cash Flow
1 |
0.2499
|
-20.61
|
24.22
|
-59
|
-20.74
|
-64.48
|
FCF margin
|
0.08%
|
-5.43%
|
5.47%
|
-12.79%
|
-6.41%
|
-15.27%
|
FCF Conversion (EBITDA)
|
0.28%
|
-
|
22.83%
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
0.36%
|
-
|
24.98%
|
-
|
-
|
-
|
Dividend per Share
2 |
0.2564
|
0.2564
|
0.2500
|
-
|
-
|
-
|
Announcement Date
|
3/15/19
|
4/23/20
|
4/23/21
|
2/25/22
|
4/23/23
|
4/25/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
436
|
421
|
389
|
235
|
181
|
126
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
0.25
|
-20.6
|
24.2
|
-59
|
-20.7
|
-64.5
|
ROE (net income / shareholders' equity)
|
15.9%
|
16%
|
13.7%
|
7.01%
|
-10.4%
|
1.22%
|
ROA (Net income/ Total Assets)
|
9.8%
|
7.68%
|
7.61%
|
3.48%
|
-5.7%
|
1.76%
|
Assets
1 |
715.1
|
1,333
|
1,274
|
1,552
|
1,339
|
469.1
|
Book Value Per Share
2 |
4.800
|
5.350
|
5.870
|
6.190
|
5.440
|
5.540
|
Cash Flow per Share
2 |
3.460
|
3.340
|
3.080
|
2.180
|
1.980
|
1.600
|
Capex
1 |
61.6
|
58.3
|
35.6
|
39.6
|
24.2
|
30.7
|
Capex / Sales
|
20.66%
|
15.36%
|
8.04%
|
8.59%
|
7.46%
|
7.28%
|
Announcement Date
|
3/15/19
|
4/23/20
|
4/23/21
|
2/25/22
|
4/23/23
|
4/25/24
|
|
1st Jan change
|
Capi.
|
---|
| -31.28% | 205M | | +73.17% | 12.38B | | -18.74% | 7.92B | | +16.15% | 7.2B | | +4.81% | 5.84B | | +5.99% | 5.07B | | +27.07% | 4.53B | | -21.67% | 3.88B | | -40.82% | 2.23B | | +1.49% | 2.02B |
Medical Equipment
|